Xeris制药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
John P. Schmid | 2 | 11,000 |
Paul R Edick | 2 | 30,000 |
Jeffrey W Sherman | 1 | 5,400 |
Shannon John Patrick Jr | 1 | 30,769 |
Dawn Halkuff | 1 | 5,410 |
Steven Pieper | 1 | 28,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 4,500 | 0 | 4,500 |
最近6个月 | 80,579 | 0 | 80,579 |
最近12个月 | 90,579 | 0 | 90,579 |
最近18个月 | 110,579 | 0 | 110,579 |
Xeris制药 内部交易
Xeris制药 最新内部交易
John P. Schmid | 董事 | 2024-03-14 | 买入 | 4,500 | 74,159 |
$2.16
|
-12.50%
|
Jeffrey W Sherman | 董事 | 2023-11-27 | 买入 | 5,400 | 113,278 |
$1.87
|
+1.07%
|
Steven Pieper | See Remarks | 2023-11-20 | 买入 | 28,000 | 1,176,912 |
$1.95
|
-3.08%
|
Dawn Halkuff | 董事 | 2023-11-20 | 买入 | 5,410 | 62,910 |
$1.84
|
+2.72%
|
Shannon John Patrick Jr | See Remarks | 2023-11-17 | 买入 | 30,769 | 1,408,575 |
$1.64
|
+15.24%
|
John P. Schmid | 董事 | 2023-11-16 | 买入 | 6,500 | 69,659 |
$1.51
|
+25.17%
|
Paul R Edick | See Remarks | 2023-08-09 | 买入 | 10,000 | 2,321,494 |
$2.38
|
-20.59%
|
Paul R Edick | See Remarks | 2022-12-13 | 买入 | 20,000 | 1,561,494 |
$1.45
|
+30.34%
|
Paul R Edick | See Remarks | 2022-05-12 | 买入 | 100,000 | 1,541,494 |
$1.4
|
+35.00%
|
Steven Prestrelski | Chief Scientific Officer | 2022-02-22 | 卖出 | 11,228 | 569,780 |
$2.42
|
-21.90%
|